To explore the potential association between the CASP8 -652 6N ins/del polymorphism and prostate cancer risk in a Chinese population, we performed a hospital-based case-control study with 406 prostate cancer cases and 408 cancer-free controls. The gene discussed is CASP8; the disease is prostate carcinoma.